Regulatory Considerations for Fluid & Imaging Biomarkers of Neurodegeneration & Neuroinflammation

Time: 8:45 am
day: Conference Day One


  • Outline the different types of biomarkers using the BEST classification and their application in clinical trials
  • Considerations for analytic and clinical validation of biomarkers
  • Considerations for use of biomarkers as surrogate endpoints